These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 37449277)

  • 1. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and associated factors of lipohypertrophy in insulin-injected patients with diabetes in selected primary care clinics in Peninsular Malaysian: A cross-sectional study.
    Hawa A; Teng CL; Devaraj NK; Saadatun A; Rawaida AL; Chong FY; Syamimi Y; Danial D; Lim PW
    Malays Fam Physician; 2023; 18():37. PubMed ID: 37449277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipohypertrophy prevalence and its associated risk factors in insulin-treated patients with type 2 diabetes in North Borneo, Malaysia.
    Nain RA; Thomas DC
    Belitung Nurs J; 2022; 8(6):521-528. PubMed ID: 37554235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipohypertrophy in Individuals with Type 2 Diabetes: Prevalence and Risk Factors.
    Sürücü HA; OKur Arslan H
    J Caring Sci; 2018 Jun; 7(2):67-74. PubMed ID: 29977876
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
    Bochanen N; Decochez K; Heleu E; Cuypers J; Vercammen C; Coremans P; Vanhaverbeke G; Shadid S; Keymeulen B; Bolsens N; De Block C
    Diabet Med; 2022 Jan; 39(1):e14672. PubMed ID: 34407260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-Related Lipohypertrophy: Lipogenic Action or Tissue Trauma?
    Barola A; Tiwari P; Bhansali A; Grover S; Dayal D
    Front Endocrinol (Lausanne); 2018; 9():638. PubMed ID: 30425682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France.
    Campinos C; Le Floch JP; Petit C; Penfornis A; Winiszewski P; Bordier L; Lepage M; Fermon C; Louis J; Almain C; Morel D; Hirsch L; Strauss KW
    Diabetes Technol Ther; 2017 Nov; 19(11):623-632. PubMed ID: 29058477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of lipohypertrophy in insulin-treated diabetes patients: A systematic review and meta-analysis.
    Deng N; Zhang X; Zhao F; Wang Y; He H
    J Diabetes Investig; 2017 Sep; 9(3):536-43. PubMed ID: 28862814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Audit of Insulin Usage and Insulin Injection Practices in a Large Indian Cohort.
    Baruah MP; Kalra S; Bose S; Deka J
    Indian J Endocrinol Metab; 2017; 21(3):443-452. PubMed ID: 28553603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK lipohypertrophy interventional study.
    Smith M; Clapham L; Strauss K
    Diabetes Res Clin Pract; 2017 Apr; 126():248-253. PubMed ID: 28288434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact.
    Ji L; Sun Z; Li Q; Qin G; Wei Z; Liu J; Chandran AB; Hirsch LJ
    Diabetes Technol Ther; 2017 Jan; 19(1):61-67. PubMed ID: 28099050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional.
    Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1224-30. PubMed ID: 27594186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices.
    Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
    Mayo Clin Proc; 2016 Sep; 91(9):1212-23. PubMed ID: 27594185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESTIMATED ECONOMIC BURDEN OF INSULIN INJECTION-RELATED LIPOHYPERTROPHY IN CHINESE PATIENTS WITH DIABETES.
    Tao L; Zhang X; Strauss K; Hirsch LJ; Chandran A
    Value Health; 2014 Nov; 17(7):A748-9. PubMed ID: 27202710
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus.
    Al Ajlouni M; Abujbara M; Batieha A; Ajlouni K
    Int J Endocrinol Metab; 2015 Apr; 13(2):e20776. PubMed ID: 25926852
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.